Cargando…
A long non‐coding RNA OLBC15 promotes triple‐negative breast cancer progression via enhancing ZNF326 degradation
BACKGROUND: The long non‐coding RNAs (lncRNAs) have been involved in various processes, including cancer. However, the function of many lncRNAs is still elusive in triple‐negative breast cancer (TNBC). METHODS: LncRNA profiling was used to screen for novel lncRNAs related to TNBC. OLBC15 expression...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439339/ https://www.ncbi.nlm.nih.gov/pubmed/32329931 http://dx.doi.org/10.1002/jcla.23304 |
_version_ | 1783572959101714432 |
---|---|
author | Deng, Chao Zhang, Bojuan Zhang, Yao Xu, Xiaogang Xiong, Deming Chen, Xiaoyan Wu, Jiaojiao |
author_facet | Deng, Chao Zhang, Bojuan Zhang, Yao Xu, Xiaogang Xiong, Deming Chen, Xiaoyan Wu, Jiaojiao |
author_sort | Deng, Chao |
collection | PubMed |
description | BACKGROUND: The long non‐coding RNAs (lncRNAs) have been involved in various processes, including cancer. However, the function of many lncRNAs is still elusive in triple‐negative breast cancer (TNBC). METHODS: LncRNA profiling was used to screen for novel lncRNAs related to TNBC. OLBC15 expression was measured via qRT‐PCR. In vitro migration and viability assays were conducted to determine the oncogenic role of OLBC15. Xenograft and metastatic models were performed to further investigate effects in vivo. RNA immunoprecipitation (RIP), mass spectrometry (MS), and fluorescence in situ hybridization (FISH) strategies were designed to identify the interaction between ZNF326 and OLBC15. RESULTS: In the current study, we have identified a novel oncogenic lncRNA termed OLBC15 via lncRNA profiling. OLBC15 is highly expressed especially in triple‐negative breast cancer. OLBC15 promoted viability and migration in breast cancer cells. Moreover, OLBC15 could accelerate metastasis and xenograft tumor growth. Mechanistic study suggested that OLBC15 could bind a well‐characterized tumor suppressor ZNF326 and OLBC15‐ZNF326 interaction resulted in ZNF326 destabilization. OLBC15 induced proteasomal ZNF326 degradation through enhanced ubiquitination. OLBC15 and ZNF326 protein expression is also negatively correlated in clinical specimens. CONCLUSIONS: Collectively, OLBC15 may serve as an oncogenic lncRNA to facilitate TNBC progression and a putative target for therapeutic anti‐breast cancer intervention. |
format | Online Article Text |
id | pubmed-7439339 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74393392020-08-21 A long non‐coding RNA OLBC15 promotes triple‐negative breast cancer progression via enhancing ZNF326 degradation Deng, Chao Zhang, Bojuan Zhang, Yao Xu, Xiaogang Xiong, Deming Chen, Xiaoyan Wu, Jiaojiao J Clin Lab Anal Research Articles BACKGROUND: The long non‐coding RNAs (lncRNAs) have been involved in various processes, including cancer. However, the function of many lncRNAs is still elusive in triple‐negative breast cancer (TNBC). METHODS: LncRNA profiling was used to screen for novel lncRNAs related to TNBC. OLBC15 expression was measured via qRT‐PCR. In vitro migration and viability assays were conducted to determine the oncogenic role of OLBC15. Xenograft and metastatic models were performed to further investigate effects in vivo. RNA immunoprecipitation (RIP), mass spectrometry (MS), and fluorescence in situ hybridization (FISH) strategies were designed to identify the interaction between ZNF326 and OLBC15. RESULTS: In the current study, we have identified a novel oncogenic lncRNA termed OLBC15 via lncRNA profiling. OLBC15 is highly expressed especially in triple‐negative breast cancer. OLBC15 promoted viability and migration in breast cancer cells. Moreover, OLBC15 could accelerate metastasis and xenograft tumor growth. Mechanistic study suggested that OLBC15 could bind a well‐characterized tumor suppressor ZNF326 and OLBC15‐ZNF326 interaction resulted in ZNF326 destabilization. OLBC15 induced proteasomal ZNF326 degradation through enhanced ubiquitination. OLBC15 and ZNF326 protein expression is also negatively correlated in clinical specimens. CONCLUSIONS: Collectively, OLBC15 may serve as an oncogenic lncRNA to facilitate TNBC progression and a putative target for therapeutic anti‐breast cancer intervention. John Wiley and Sons Inc. 2020-04-24 /pmc/articles/PMC7439339/ /pubmed/32329931 http://dx.doi.org/10.1002/jcla.23304 Text en © 2020 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Articles Deng, Chao Zhang, Bojuan Zhang, Yao Xu, Xiaogang Xiong, Deming Chen, Xiaoyan Wu, Jiaojiao A long non‐coding RNA OLBC15 promotes triple‐negative breast cancer progression via enhancing ZNF326 degradation |
title | A long non‐coding RNA OLBC15 promotes triple‐negative breast cancer progression via enhancing ZNF326 degradation |
title_full | A long non‐coding RNA OLBC15 promotes triple‐negative breast cancer progression via enhancing ZNF326 degradation |
title_fullStr | A long non‐coding RNA OLBC15 promotes triple‐negative breast cancer progression via enhancing ZNF326 degradation |
title_full_unstemmed | A long non‐coding RNA OLBC15 promotes triple‐negative breast cancer progression via enhancing ZNF326 degradation |
title_short | A long non‐coding RNA OLBC15 promotes triple‐negative breast cancer progression via enhancing ZNF326 degradation |
title_sort | long non‐coding rna olbc15 promotes triple‐negative breast cancer progression via enhancing znf326 degradation |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439339/ https://www.ncbi.nlm.nih.gov/pubmed/32329931 http://dx.doi.org/10.1002/jcla.23304 |
work_keys_str_mv | AT dengchao alongnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation AT zhangbojuan alongnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation AT zhangyao alongnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation AT xuxiaogang alongnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation AT xiongdeming alongnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation AT chenxiaoyan alongnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation AT wujiaojiao alongnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation AT dengchao longnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation AT zhangbojuan longnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation AT zhangyao longnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation AT xuxiaogang longnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation AT xiongdeming longnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation AT chenxiaoyan longnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation AT wujiaojiao longnoncodingrnaolbc15promotestriplenegativebreastcancerprogressionviaenhancingznf326degradation |